[go: up one dir, main page]

GB0723721D0 - Combination therapy 793 - Google Patents

Combination therapy 793

Info

Publication number
GB0723721D0
GB0723721D0 GB0723721A GB0723721A GB0723721D0 GB 0723721 D0 GB0723721 D0 GB 0723721D0 GB 0723721 A GB0723721 A GB 0723721A GB 0723721 A GB0723721 A GB 0723721A GB 0723721 D0 GB0723721 D0 GB 0723721D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0723721A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0723721A priority Critical patent/GB0723721D0/en
Publication of GB0723721D0 publication Critical patent/GB0723721D0/en
Priority to JP2010502569A priority patent/JP2010523634A/en
Priority to CN200880018909A priority patent/CN101678001A/en
Priority to PCT/GB2008/001266 priority patent/WO2008125820A1/en
Priority to EP08719008A priority patent/EP2134340A1/en
Priority to US12/595,746 priority patent/US20100130519A1/en
Ceased legal-status Critical Current

Links

GB0723721A 2007-04-13 2007-12-05 Combination therapy 793 Ceased GB0723721D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0723721A GB0723721D0 (en) 2007-12-05 2007-12-05 Combination therapy 793
JP2010502569A JP2010523634A (en) 2007-04-13 2008-04-11 Combination therapy comprising AZD2171 and AZD6244 or MEK inhibitor II
CN200880018909A CN101678001A (en) 2007-04-13 2008-04-11 Combination therapy comprising AZD2171 and AZD6244 or MEK-inhibitor II
PCT/GB2008/001266 WO2008125820A1 (en) 2007-04-13 2008-04-11 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii
EP08719008A EP2134340A1 (en) 2007-04-13 2008-04-11 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii
US12/595,746 US20100130519A1 (en) 2007-04-13 2008-04-11 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0723721A GB0723721D0 (en) 2007-12-05 2007-12-05 Combination therapy 793

Publications (1)

Publication Number Publication Date
GB0723721D0 true GB0723721D0 (en) 2008-01-16

Family

ID=38982974

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0723721A Ceased GB0723721D0 (en) 2007-04-13 2007-12-05 Combination therapy 793

Country Status (1)

Country Link
GB (1) GB0723721D0 (en)

Similar Documents

Publication Publication Date Title
IL196559A0 (en) Combination therapy
IL199992A0 (en) Combination therapy
ZA200906525B (en) Therapeutic agents
GB0702457D0 (en) New combination 666
IL196556A0 (en) Combination therapy
EP2054061A4 (en) Combination therapy
GB0723747D0 (en) Therapeutic agents
GB0703999D0 (en) New combination 667
GB0719518D0 (en) Therapy
GB0724340D0 (en) Novel Therapeutic Agents
ZA200902203B (en) Combination therapy
EP2211863A4 (en) Combination therapy
GB0700284D0 (en) Combination therapy
GB0723748D0 (en) Therapeutic agents
GB0808690D0 (en) Therapeutic use
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
GB0723721D0 (en) Combination therapy 793
GB0705917D0 (en) Therapy
GB0703963D0 (en) Therapy
GB0610708D0 (en) Combination therapy
GB0610706D0 (en) Combination therapy
GB0711402D0 (en) Combination 501
GB0711078D0 (en) Combination 500
GB0721012D0 (en) New therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)